It is an important global production and export base for antipyretic and analgesic drugs, as well as a major domestic manufacturer of cardiovascular, anti infective, neurological, and steroid hormone drugs. It has four major business segments: chemical raw materials, pharmaceutical preparations, pharmaceutical intermediates, and e-commerce. It has five industrial parks and 13 subsidiaries with an annual production capacity of 50000 tons of chemical raw materials, 500000 tons of pharmaceutical intermediates, 32 billion tablets (granules) of solid preparations, and 1.5 billion injections .
